Atlas Trials

AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer

Clinical trial NCT00303862 · TERMINATED

Trial details

NCT number
NCT00303862
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
Start date
2006-03-01
Primary completion
2011-03-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.